Antioxidant therapy: Reducing malaria severity?

Critical Care Medicine

Volumn 37, Issue 2, 2009, Pages 758-760

  Ackerman, Hans C ^a,b   Beaudry, Steven D ^a   Fairhurst, Rick M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Artesunate; Cytoadherence; Endothelium; Glucose 6 phosphate dehydrogenase deficiency; Lactate; N acetylcysteine; Oxidative stress; Plasmodium falciparum

Indexed keywords

ACETYLCYSTEINE; ARTESUNATE; CYTOKINE; HEMOGLOBIN; ISOPROSTANE DERIVATIVE; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE SYNTHASE; QUININE; REACTIVE OXYGEN METABOLITE; THROMBOPLASTIN;

CARDIOGENIC SHOCK; CELL ADHESION; CYTOKINE RELEASE; DISEASE SEVERITY; EDITORIAL; ENDOTHELIUM CELL; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; GENETIC POLYMORPHISM; GLASGOW COMA SCALE; GLYCOGEN STORAGE DISEASE TYPE 1; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HOSPITAL ADMISSION; HUMAN; HYPOVOLEMIA; IMMUNOCOMPETENT CELL; LACTATE BLOOD LEVEL; MALARIA FALCIPARUM; MICROANGIOPATHY; MICROVASCULATURE; MORTALITY; MOSQUITO; OXIDATIVE STRESS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; SURVIVAL; THROMBOCYTE AGGREGATION; TISSUE PERFUSION; TRAVEL; URINE LEVEL;

ANTIOXIDANTS; HUMANS; MALARIA, FALCIPARUM; SEVERITY OF ILLNESS INDEX;

EID: 67650386101     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318194d5de     Document Type: Editorial

References (15)

1. Snow RW, Guerra CA, Noor AM, et al: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434:214-217
2. Dondorp A, Nosten F, Stepniewska K, et al: Artesunate versus quinine for treatment of severe falciparum malaria: A randomised trial. Lancet 2005; 366:717-725
3. Planche T, Onanga M, Schwenk A, et al: Assessment of volume depletion in children with malaria. PLoS Med 2004; 1:e18
4. Ockenhouse CF, Ho M, Tandon NN, et al: Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: Differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis 1991; 164:163-169
5. Francischetti IM, Seydel KB, Monteiro RQ: Blood coagulation, inflammation, and malaria. Microcirculation 2008; 15:81-107
6. Taylor TE, Fu WJ, Carr RA, et al: Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 2004; 10:143-145
7. Gramaglia I, Sobolewski P, Meays D, et al: Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med 2006; 12:1417-1422
8. Charunwatthana P, Faiz MA, Ruangveerayut R, et al: N- acetylcysteine as adjunctive treatment in severe malaria: A randomized double blinded placebo controlled-clinical trial. Crit Care Med 2009; 37:516-522
9. Griffiths MJ, Ndungu F, Baird KL, et al: Oxida-tive stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria. Br J Haematol 2001; 113:486-491
10. Dondorp A, Angus BJ, Hardeman MR, et al: Prognostic significance of reduced red blood cell deformability in severe falciparum malaria. Am J Trop Med Hyg 1997; 57:507-511
11. Nuchsongsin F, Chotivanich K, Charunwat-thana P, et al: Effects of malaria heme prod- ucts on red blood cell deformability. Am J Trop Med Hyg 2007; 77:617-622
12. Arreesrisom P, Dondorp AM, Looareesuwan S, et al: Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate. Parasitol Int 2007; 56:221-226
13. Cholera R, Brittain NJ, Gillrie MR, et al: Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci USA 2008; 105:991-996
14. Taoufiq Z, Pino P, Dugas N, et al: Transient supplementation of superoxide dismutase protects endothelial cells against Plasmodium falciparum-induced oxidative stress. Mol Biochem Parasitol 2006; 150:166-173
15. Watt G, Jongsakul K, Ruangvirayuth R: A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. QJM 2002; 95:285-290